A Study to Evaluate Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation

Overview

About this study

The objectives of this study are to examine the prevalence of comorbid sleep disordered breathing (SDB) and insomnia in post-MI patients enrolled in cardiac rehabilitation (CR), to assess whether post-MI CR patients with comorbid SDB and insomnia exhibit a more unfavorable CV profile than those without, and to determine whether post-MI CR patients with comorbid SDB and insomnia show less adherence to CR than those without.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Patients will be >18 years old

- Referred to CR following admitted to the hospital with a documented diagnosis of acute
coronary syndrome

- Referred to CR following admission to the hospital with a documented diagnosis of ST-
elevation myocardial infarction (STEMI),

- Referred to CR following admission to the hospital with a documented diagnosis of non-
STEMI

- Referred to CR following admission to the hospital with a documented diagnosis of
unstable angina

- Referred to CR following admission to the hospital with a documented diagnosis of post
coronary artery bypass surgery

- Referred to CR following admission to the hospital after percutaneous coronary
intervention (with or without stent placement).

Exclusion Criteria:

- heart failure with reduced ejection fraction

- peripheral artery disease

- valve or pericardial surgery

- heart transplantation

- patients unable to provide informed consent

- patients unable to speak and read English

- night shift workers

- pregnant women

- those who will only attend full home-based CR.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 8/2/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Amanda Bonikowske, Ph.D.

Open for enrollment

Contact information:

Rebecca Jobes

(507) 538-7425

RSTCVRUPrevent@mayo.edu

More information

Publications

Publications are currently not available